You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

MYCIFRADIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Mycifradin, and what generic alternatives are available?

Mycifradin is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in MYCIFRADIN is neomycin sulfate. There are nineteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the neomycin sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Mycifradin

A generic version of MYCIFRADIN was approved as neomycin sulfate by XGEN PHARMS on July 28th, 2006.

  Try a Trial

Drug patent expirations by year for MYCIFRADIN

US Patents and Regulatory Information for MYCIFRADIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn MYCIFRADIN neomycin sulfate SOLUTION;ORAL 050285-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pharmacia And Upjohn MYCIFRADIN neomycin sulfate TABLET;ORAL 060520-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.